Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
The review deals with the discussion of different mechanisms of the antitumor action of lipopolysaccharides (LPS), including the induction of endogenous cell mediators, the development of inflammatory and immune response and systemic metabolic changes. The complex action of these factors on the levels of cells, tissues, organs and the whole body led, in some cases, to the suppression or hemorrhagic necrosis of the tumor. These cases were regarded as analogous to the development of the septic syndrome when a cascade of reactions leading to the resorption of tumors was initiated and to chronic inflammation resulting, on the contrary, in the formation of pretumor status. The data on the role of cytokines in carcinogenesis are presented and the possible causes of established contradictions are discussed. The prospects of using LPS in the therapy of oncological diseases are discussed.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!